</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →
3004.20.00.65/Oracea Doxycycline 40mg Modified-Release Capsules/Canada

Oracea Doxycycline 40mg Modified-Release Capsules from Canada

Oracea brand 40mg doxycycline capsules with modified-release for anti-inflammatory treatment of rosacea, not antibacterial dosing. Still under HTS 3004.20.00.65 as it contains doxycycline salts in measured retail doses for therapeutic use.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.05.860%Universal product exemption (U.S. note 52(b))
Calculate with your customs valueVerify classification with AI

Import Tips

• Include bioequivalence data for modified-release formulations

• Label as sub-antimicrobial dose if applicable to match therapeutic claims

• Ensure packaging prevents moisture degradation common in doxycycline

Oracea Doxycycline 40mg Modified-Release Capsules from Canada — Import Duty Rate | HTS 3004.20.00.65